Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Edison Pharmaceuticals Inc.
DescriptionReversible redox cofactor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCentral nervous system (CNS) disorders
Indication DetailsTreat central nervous system (CNS) disorders in adults
Regulatory Designation
PartnerSumitomo Dainippon Pharma Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today